TABLE 2–1 Vaccines in Widespread Use, 1985–2020

1985

2000

2020a

Adult influenza

Adult influenza

Adult influenzac

Adult pneumococcal polysaccharide

Adult pneumococcal polysaccharide

Adult pneumococcal polysaccharide

Diphtheria, pertussis, tetanus, and components

Diphtheria, tetanus, acellular pertussis, and components b

DTaPc

Measles, mumps, and rubella

MMRb

Measles, mumps, rubella, and varicellac

Oral poliovirus

Inactivated poliovirusb

H. influenzae type bb

Hepatitis Ab

Hepatitis Bb

Varicellab

Pediatric conjugate of pneumococcal polysaccharide

Borrelia burgdorferi

Meningococcal polysaccharide A,C,Y,W-135

Eradication of polio expected

Hibc

Hepatitis Ac

Hepatitis Bc

Varicella with MMR

Pediatric conjugate of pneumococcal polysaccharidec

Borrelia burgdorferi

Conjugated meningococcal polysaccharide A,B,C,Y,W-135c

Adult tetanus, diphtheria, acellular pertussis, and componentsc

Chlamydia

Coccidioides immites

Cytomegalovirus

Enterotoxigenic E.coli

Epstein-Barr

Helicobacter pyloric

Hepatitis Cc

Herpes simplex

Histoplasma capsulatum

Human papillomavirusc

Child influenzac

Insulin-dependent diabetes mellitus (therapeutic)

Melanoma (therapeutic)

Multiple sclerosis (therapeutic)

Mycobacterium tuberculosis

Neisseria gonorrhea

Neisseria meningitidis B

Parainfluenzac

Respiratory syncytial virusc

Rheumatoid arthritis (therapeutic)

Rotavirusc

Shigella

Streptococcus, Group Ac

Streptococcus, Group B

aPriority candidate vaccines, drawn from IOM, 1999b.

bVaccines covered by Vaccines for Children (VFC) as of February 2000.

cVaccines likely to be recommended for universal use (including VFC coverage for childhood vaccines).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement